학술논문
Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18–70 years
Document Type
Article
Author
Gholami, F.; Ahi, M.; Sheidaei, A.; Gohari, K.; Rahimi, Z.; Ansarifar, A.; Bakhshande, H.; Solaymani Dodaran, M.; Hamidi Farahani, R.; Karimi Rahjerdi, A.; Basiri, P.; Moradi, M.; Jahangiri, A.; Naderi, K.; Ghasemi, S.; Khatami, P.; Honari, M.; Khodaverdloo, S.; Shooshtari, M.; Mehr Azin, H.; Moradi, S.; Shafaghi, B.; Allahyari, H.; Monazah, A.; Khodaei Poor, A.; Taghva, Z.; Karimi Nia, M.; Forooghizade, M.
Source
In: BMC Infectious Diseases . (BMC Infectious Diseases, December 2023, 23(1))
Subject
Language
English
ISSN
14712334